Diagnosis and treatment of acute rejection in the first case of human living-related small bowel transplantation with a long-term survival in China

World J Gastroenterol. 2005 Sep 14;11(34):5332-5. doi: 10.3748/wjg.v11.i34.5332.

Abstract

Aim: To report the comprehensive diagnosis and treatment of acute rejection in the first case of living-related small bowel transplantation with a long-term survival in China.

Methods: A 18-year-old boy with short gut syndrome underwent living-related small bowel transplantation, with the graft taken from his father (44-year old). A segment of 150-cm distal small bowel was resected from the donor. The ileo-colic artery and vein from the donor were anastomosed to the infrarenal aorta and vena cava of the recipient respectively. The intestinal continuity was restored with an end-to-end anastomosis between the recipient jejunum and donor ileum, and the distal end was fistulized. FK506, MMF and prednisone were initially used for post-transplant immunosuppression. Endoscopic observation and mucosal biopsies of the graft were carried out through the terminal ileum enterostomy; serum was collected to detect the levels of IL-2R, IL-4, IL-6 and IL-8. The change of the graft secretion and absorption was observed.

Results: Acute rejection was diagnosed promptly and cured. The patient was in good health, 5 years after living-related small bowel transplantation.

Conclusion: The correct diagnosis and treatment of acute rejection are the key to the long-term survival after living-related small bowel transplantation.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acute Disease
  • Adolescent
  • Adult
  • Graft Rejection / diagnosis*
  • Graft Rejection / drug therapy*
  • Graft Rejection / pathology
  • Humans
  • Immunosuppressive Agents / administration & dosage*
  • Intestine, Small / transplantation*
  • Living Donors*
  • Male
  • Short Bowel Syndrome / surgery

Substances

  • Immunosuppressive Agents